{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-24-008680","form_type":"8-K","ticker":"ADMA","cik":"0001368514","company_name":"ADMA BIOLOGICS, INC.","filed_at":"2024-02-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.966726+00:00","generated_at":"2026-06-05T21:52:28.368495+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"ADMA Biologics launches AI program ADMAlytics, automates plasma pooling in first commercial batch","bullets":["ADMAlytics combines generative AI and machine learning to optimize production processes.","First successful commercial use: automated plasma pooling for ASCENIV production.","Broader implementation across supply chain and operations expected to yield efficiencies.","CEO Adam Grossman says ADMAlytics supports earnings growth trajectory and continuity of patient care."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-24-008680","json":"https://secwatch.observer/filing/0001140361-24-008680.json","markdown":"https://secwatch.observer/filing/0001140361-24-008680.md","text":"https://secwatch.observer/filing/0001140361-24-008680.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1368514/000114036124008680/0001140361-24-008680-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1368514/000114036124008680/ef20022054_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T21:52:28.368495+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}